Eight Hantavirus cases have been reported, with three deaths. Six cases are confirmed as Andes virus. The World Health Organization assesse...

Moderna had earlier posted a loss of $2.52 per share a year earlier, while analysts expected a loss of $3.96 per share.

The Centre told the Supreme Court that COVID-19 vaccination saved lives during the pandemic. This statement was made during a hearing of a ...

The experts will review its data for its use as a standalone vaccine and will also weigh its benefits as a booster shot and take a decision...

The government has acted swiftly to clear the confusion over Covid-19 vaccination documents being provided by international travellers, som...

Zydus Cadila's COVID-19 vaccine ZyCov-D, which has been cleared by India's drug regulator for those aged 12 years and above, will only be a...

Switzerland has cleared the BioNTech-Pfizer, Moderna and Johnson & Johnson vaccines for use. However, national medical regulator Swissmedic...

Earlier, the WHO said it will take a call on granting Emergency Use Listing (EUL) status for Bharat Biotech's COVID-19 vaccine Covaxin next...

While the drug regulator has given a nod to Biological E to manufacture the vaccine at its plant in Telangana, its launch looks unlikely ti...

Early stage trials of the vaccine candidate, BBV154, has been completed in subjects aged 18 to 60 years, and the doses were found to be wel...

The plan provides for setting up of a COVID-19 Vaccine Response Team (CVRT) at each Air Cargo/Courier Terminal. So far, India has allowed d...

Pakistan, which has recorded more than 550,000 cases of COVID-19 and more than 12,000 deaths, is still largely reliant on the GAVI/WHO COVA...

Dr Reddy’s had in September entered into a partnership with Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V –...

SII has already manufactured around 50 million doses of its Covid vaccine called Covishield, which is based on the technology from drugmake...

Six vaccines, including Astra Zeneca's Covidshield and Bharat Biotech's Covaxin, are in trial stages, Federal health secretary Rajesh Bhush...

The firm, in its application submitted to the drug regulator, has sought permission to import the vaccine for sale and distribution in the ...

Britain said that it had changed its rules around administering and distributing vaccines to make the speedy rollout of any COVID-19 vaccin...